News and Announcements
Leaf Resources in top 5 for global renewable chemistry award
- Published July 16, 2015 12:37PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th July 2015, ASX Announcement
Pioneering Australian company, Leaf Resources, was selected from an international field of 38 companies to be one of the five finalists for the Sofinnova Chemistry Start-up Award.
The award is being held in conjunction with BIO World Congress on Industrial Biotechnology in Montreal, Columbia from 19-22 July 2015.
Leaf Resources has developed a unique new process that promises to revolutionise bio manufacturing on a global scale, and nudge fossil fuel-based chemicals and plastics out of the market.
Leaf Resources’ Glycell process uses glycerol as the main reagent in their process to make cellulosic sugars – the key component in bio-chemicals and bio-plastics – from biomass such as waste from agriculture. And it does so for a fraction of the cost of technologies currently used as alternatives to fossil fuel-based industry processes.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
